Search Results - "Boczkowski, David"

Refine Results
  1. 1

    Vaccination against the forkhead family transcription factor foxp3 enhances tumor immunity by NAIR, Smita, BOCZKOWSKI, David, FASSNACHT, Martin, PISETSKY, David, GILBOA, Eli

    Published in Cancer research (Chicago, Ill.) (2007)
    “…Depletion of CD4+CD25+ regulatory T cells (Treg) by treatment with alphaCD25 antibody synergizes with vaccination protocols to engender protective immunity in…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Spatial biology analysis reveals B cell follicles in secondary lymphoid structures may regulate anti-tumor responses at initial melanoma diagnosis by Therien, Aaron D, Beasley, Georgia M, Rhodin, Kristen E, Farrow, Norma E, Tyler, Douglas S, Boczkowski, David, Al-Rohil, Rami N, Holl, Eda K, Nair, Smita K

    Published in Frontiers in immunology (15-08-2022)
    “…B cells are key regulators of immune responses in melanoma. We aimed to explore differences in the histologic location and activation status of B cell…”
    Get full text
    Journal Article
  4. 4

    Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts by LEE, Jaewoo, FASSNACHT, Martin, NAIR, Smita, BOCZKOWSKI, David, GILBOA, Eli

    Published in Cancer research (Chicago, Ill.) (01-12-2005)
    “…Murine studies have shown that immunologic targeting of the tumor vasculature, a key element of the tumor stroma, can lead to protective immunity in the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Synergy between tumor immunotherapy and antiangiogenic therapy by Nair, Smita, Boczkowski, David, Moeller, Benjamin, Dewhirst, Mark, Vieweg, Johannes, Gilboa, Eli

    Published in Blood (01-08-2003)
    “…This study tested the hypothesis that combination of antiangiogenic therapy and tumor immunotherapy of cancer is synergistic. To inhibit angiogenesis, mice…”
    Get full text
    Journal Article
  7. 7

    Immunologic targeting of FOXP3 in inflammatory breast cancer cells by Nair, Smita, Aldrich, Amy J, McDonnell, Eoin, Cheng, Qing, Aggarwal, Anshu, Patel, Pujan, Williams, Monique M, Boczkowski, David, Lyerly, H Kim, Morse, Michael A, Devi, Gayathri R

    Published in PloS one (14-01-2013)
    “…The forkhead transcription factor FOXP3 is necessary for induction of regulatory T lymphocytes (Tregs) and their immunosuppressive function. We have previously…”
    Get full text
    Journal Article
  8. 8

    Induction of CD4+ and CD8+ T-Cell Responses to the Human Stromal Antigen, Fibroblast Activation Protein: Implication for Cancer Immunotherapy by FASSNACHT, Martin, LEE, Jaewoo, MILAZZO, Caterina, BOCZKOWSKI, David, ZHEN SU, NAIR, Smita, GILBOA, Eli

    Published in Clinical cancer research (01-08-2005)
    “…Purpose: The propensity of tumor cells to escape immune elimination could limit, if not defeat, the long-term benefits of effective immunotherapeutic…”
    Get full text
    Journal Article
  9. 9

    Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization by Zhao, Fei, Xiao, Christine, Evans, Kathy S., Theivanthiran, Tbalamayooran, DeVito, Nicholas, Holtzhausen, Alisha, Liu, Juan, Liu, Xiaojing, Boczkowski, David, Nair, Smita, Locasale, Jason W., Hanks, Brent A.

    Published in Immunity (Cambridge, Mass.) (16-01-2018)
    “…Despite recent advances, many cancers remain refractory to available immunotherapeutic strategies. Emerging evidence indicates that the tolerization of local…”
    Get full text
    Journal Article
  10. 10

    Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs by Brown, Michael C, Holl, Eda K, Boczkowski, David, Dobrikova, Elena, Mosaheb, Mubeen, Chandramohan, Vidya, Bigner, Darell D, Gromeier, Matthias, Nair, Smita K

    Published in Science translational medicine (20-09-2017)
    “…Tumors thrive in an immunosuppressive microenvironment that impedes antitumor innate and adaptive immune responses. Thus, approaches that can overcome…”
    Get more information
    Journal Article
  11. 11

    The Quest for mRNA Vaccines by Gilboa, Eli, Boczkowski, David, Nair, Smita K

    Published in Nucleic acid therapeutics (01-12-2022)
    “…The success of mRNA vaccines against COVID-19 is nothing short of a medical revolution. Given its chemical lability the use of mRNA as a therapeutic has been…”
    Get more information
    Journal Article
  12. 12

    Cancer mRNA vaccines: clinical advances and future opportunities by Sayour, Elias J., Boczkowski, David, Mitchell, Duane A., Nair, Smita K.

    Published in Nature reviews. Clinical oncology (01-07-2024)
    “…mRNA vaccines have been revolutionary in terms of their rapid development and prevention of SARS-CoV-2 infections during the COVID-19 pandemic, and this…”
    Get full text
    Journal Article
  13. 13

    Controlling cancer-induced inflammation with a nucleic acid scavenger prevents lung metastasis in murine models of breast cancer by Holl, Eda K., Frazier, Victoria, Landa, Karenia, Boczkowski, David, Sullenger, Bruce, Nair, Smita K.

    Published in Molecular therapy (05-05-2021)
    “…Tumor cells release nucleic acid-containing proinflammatory complexes, termed nucleic acid-containing damage-associated molecular patterns (NA DAMPs),…”
    Get full text
    Journal Article
  14. 14

    Assembling OX40 Aptamers on a Molecular Scaffold to Create a Receptor-Activating Aptamer by Dollins, Claudia M., Nair, Smita, Boczkowski, David, Lee, Jaewoo, Layzer, Juliana M., Gilboa, Eli, Sullenger, Bruce A.

    Published in Chemistry & biology (21-07-2008)
    “…We show that a molecular scaffold can be utilized to convert a receptor binding aptamer into a receptor agonist. Many receptors (including tumor necrosis…”
    Get full text
    Journal Article
  15. 15

    Targeting DAMP-induced inflammation to prevent breast cancer metastasis and improve anti-tumor immunity by Frazier, Victoria N, Holl, Eda, Boczkowski, David, Sullenger, Bruce, Nair, Smita K

    Published in The Journal of immunology (1950) (01-05-2019)
    “…Abstract Biomarkers associated with systemic inflammation correlate with poor prognosis in cancer patients. Circulating cell-free DNA (cfDNA) is released…”
    Get full text
    Journal Article
  16. 16

    Oncolytic poliovirus immunotherapy for breast cancer by Frazier, Victoria N, Holl, Eda, Brown, Michael, Boczkowski, David, Landa, Karenia, Hwang, Shelley, Gromeier, Matthias, Nair, Smita K

    Published in The Journal of immunology (1950) (01-05-2020)
    “…Abstract Oncolytic poliovirus PVSRIPO is a recombinant, non-pathogenic polio:rhinovirus chimera that enters cells via the poliovirus receptor CD155. CD155…”
    Get full text
    Journal Article
  17. 17

    RNA as performance-enhancers for dendritic cells by Boczkowski, David, Nair, Smita

    Published in Expert opinion on biological therapy (01-04-2010)
    “…Although studies have demonstrated that antigen-loaded dendritic cells (DC) elicit antigen-specific immune responses, the clinical benefit from DC-based cancer…”
    Get more information
    Journal Article
  18. 18

    Abstract P3-01-03: Modulating inflammation with nucleic acid scavengers to prevent breast cancer metastasis by Nair, Smita, Holl, Eda, Landa, Karenia, Frazier, Victoria, Eteshola, Elias, Boczkowski, David, Rempel, Rachel, Hwang, Shelley, Sullenger, Bruce

    Published in Cancer research (Chicago, Ill.) (15-02-2020)
    “…Abstract Rationale: Chronic inflammation is a hallmark of cancer. Inflammation, whether it is an underlying baseline condition or induced/exacerbated due to…”
    Get full text
    Journal Article
  19. 19

    Targeting inflammation to prevent breast cancer metastasis by Holl, Eda K., Frazier, Victoria, Boczkowski, David, Sullenger, Bruce, Nair, Smita K.

    Published in The Journal of immunology (1950) (01-05-2018)
    “…Abstract Biomarkers associated with systemic inflammation correlate with poor prognosis in cancer patients. Circulating cell-free DNA (cfDNA) is released…”
    Get full text
    Journal Article
  20. 20

    Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells by NAIR, Smita K, DE LEON, Gabriel, SAMPSON, John H, MITCHELL, Duane A, BOCZKOWSKI, David, SCHMITTLING, Robert, WEIHUA XIE, STAATS, Janet, LIU, Rebecca, JOHNSON, Laura A, WEINHOLD, Kent, ARCHER, Gary E

    Published in Clinical cancer research (15-05-2014)
    “…Despite aggressive conventional therapy, glioblastoma (GBM) remains uniformly lethal. Immunotherapy, in which the immune system is harnessed to specifically…”
    Get full text
    Journal Article